Home > Market > Market Stats >  Aurobindo Pharma

Company Summary

AUROBINDO PHARMA SUMMARY

Aurobindo Pharma is trading 1.61% upper at Rs 463.60 as compared to its last closing price. Aurobindo Pharma has been trading in the price range of 465.1 & 455.05. Aurobindo Pharma has given -37.41% in this year & -3.82% in the last 5 days.

 

Aurobindo Pharma has TTM P/E ratio 14.17 as compared to the sector P/E of 28.26. There are 29 analysts who have initiated coverage on Aurobindo Pharma. There are 10 analysts who have given it a strong buy rating & 11 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.

 

The company posted a net profit of 409.45 Crores in its last quarter.

 

Listed peers of Aurobindo Pharma include Aurobindo Pharma (1.61%), Pfizer (1.59%), Astrazeneca Pharma India (0.2%) etc.

FAQs about Aurobindo Pharma

Aurobindo Pharma is trading at 463.60 as on 25 Nov, 2022 3:29:37 PM. This is 1.61% upper as compared to its previous closing price of 456.25
The market capitalization of Aurobindo Pharma is 26932.67 Cr as on 25 Nov, 2022 3:29:37 PM.
The average broker rating on Aurobindo Pharma is Buy. The breakup of analyst rating is given below -
  • 0 analysts have given a strong sell rating
  • 2 analysts have given a sell rating
  • 6 analysts have given a hold rating
  • 11 analysts have given a buy rating
  • 10 analysts have given a strong buy rating
The 52 wk high for Aurobindo Pharma is 742.25 whereas the 52 wk low is 455.05
Aurobindo Pharma can be analyzed on the following key metrics -
  • TTM P/E: 14.17
  • Sector P/E: 28.26
  • Dividend Yield: 1.31%
  • D/E ratio: -
Aurobindo Pharma reported a net profit of 2648.15 Cr in 2022.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout